|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Bizuayehu HM, Ahmed KY, Kibret GD, Dadi
AF, Belachew SA, Bagade T, Tegegne TK, Venchiarutti RL, Kibret KT,
Hailegebireal AH, et al: Global disparities of cancer and its
projected burden in 2050. JAMA Netw Open. 7:e24431982024.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Kratzer TB, Giaquinto AN, Sung
H and Jemal A: Cancer statistics, 2025. CA Cancer J Clin. 75:10–45.
2025.PubMed/NCBI
|
|
4
|
Song X, Luo Y, Ma L, Hu X, Simal-Gandara
J, Wang LS, Bajpai VK, Xiao J and Chen F: Recent trends and
advances in the epidemiology, synergism, and delivery system of
lycopene as an anti-cancer agent. Semin Cancer Biol. 73:331–346.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Atanasov AG, Zotchev SB, Dirsch VM;
International Natural Product Sciences Taskforce, ; Supuran CT:
Natural products in drug discovery: Advances and opportunities. Nat
Rev Drug Discov. 20:200–216. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kang H, Hoang DH, Valerio M, Pathak K,
Graff W, LeVee A, Wu J, LaBarge MA, Frankhouser D, Rockne RC, et
al: Pharmacological activity of OST-01, a natural product from
baccharis coridifolia, on breast cancer cells. J Hematol Oncol.
18:162025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin X and Zhang J, Chu Y, Nie Q and Zhang
J: Berberine prevents NAFLD and HCC by modulating metabolic
disorders. Pharmacol Ther. 254:1085932024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang YH, Zhang RR, Yin Y, Tan GF, Wang GL,
Liu H, Zhuang J, Zhang J, Zhuang FY and Xiong AS: Advances in
engineering the production of the natural red pigment lycopene: A
systematic review from a biotechnology perspective. J Adv Res.
46:31–47. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei RR, Lin QY, Adu M, Huang HL, Yan ZH,
Shao F, Zhong GY, Zhang ZL, Sang ZP, Cao L and Ma QG: The sources,
properties, extraction, biosynthesis, pharmacology, and application
of lycopene. Food Funct. 14:9974–9998. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grabowska M, Wawrzyniak D, Rolle K,
Chomczynski P, Oziewicz S, Jurga S and Barciszewski J: Let food be
your medicine: nutraceutical properties of lycopene. Food Funct.
10:3090–3102. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kulawik A, Cielecka-Piontek J and Zalewski
P: The importance of antioxidant activity for the health-promoting
effect of lycopene. Nutrients. 15:38212023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li N, Wu X, Zhuang W, Xia L, Chen Y, Wu C,
Rao Z, Du L, Zhao R, Yi M, et al: Tomato and lycopene and multiple
health outcomes: Umbrella review. Food Chem. 343:1283962021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amorim ADGN, Vasconcelos AG, Souza J,
Oliveira A, Gullon B, de Souza de Almeida Leite JR and Pintado M:
Bio-availability, anticancer potential, and chemical data of
lycopene: An overview and technological prospecting. Antioxidants
(Basel). 11:3602022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mazidi M, Ferns GA and Banach M: A high
consumption of tomato and lycopene is associated with a lower risk
of cancer mortality: Results from a multi-ethnic cohort. Public
Health Nutr. 23:1569–1575. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eliassen AH, Liao X, Rosner B, Tamimi RM,
Tworoger SS and Hankinson SE: Plasma carotenoids and risk of breast
cancer over 20 y of follow-up. Am J Clin Nutr. 101:1197–1205. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhuang E, Uchio E, Lilly M, Zi X and
Fruehauf JP: A phase II study of docetaxel plus lycopene in
metastatic castrate resistant prostate cancer. Biomed Pharmacother.
143:1122262021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sahin K, Tuzcu M, Sahin N, Akdemir F,
Ozercan I, Bayraktar S and Kucuk O: Inhibitory effects of
combination of lycopene and genistein on 7,12-dimethyl
benz(a)anthracene-induced breast cancer in rats. Nutr Cancer.
63:1279–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mennati A, Rostamizadeh K, Manjili HK,
Fathi M and Danafar H: Co-delivery of siRNA and lycopene
encapsulated hybrid lipid nanoparticles for dual silencing of
insulin-like growth factor 1 receptor in MCF-7 breast cancer cell
line. Int J Biol Macromol. 200:335–349. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Michael McClain R and Bausch J: Summary of
safety studies conducted with synthetic lycopene. Regul Toxicol
Pharmacol. 37:274–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shao A and Hathcock JN: Risk assessment
for the carotenoids lutein and lycopene. Regul Toxicol Pharmacol.
45:289–298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trumbo PR: Are there adverse effects of
lycopene exposure? J Nutr. 135:2060S–2061S. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Imran M, Ghorat F, Ul-Haq I, Ur-Rehman H,
Aslam F, Heydari M, Shariati MA, Okuskhanova E, Yessimbekov Z,
Thiruvengadam M, et al: Lycopene as a natural antioxidant used to
prevent human health disorders. Antioxidants (Basel). 9:7062020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
National Academy of Medicine, . Dietary
Reference Intakes for Vitamin C, Vitamin E, Selenium, and
Carotenoids. National Academies Press; Washington, DC: 2000
|
|
24
|
Aguilar F, Autrup H, Barlow S, Castle L,
Crebelli R, Dekant W, Engel KH, Gontard N, Gott D, Grilli S, et al:
Use of lycopene as a food colour scientific opinion of the panel on
food additives, flavourings, processing aids and materials in
contact with food. efsa J. 674:1–66. 2008.
|
|
25
|
Kavanaugh CJ, Trumbo PR and Ellwood KC:
The U.S. Food and drug administration's evidence-based review for
qualified health claims: tomatoes, lycopene, and cancer. J Natl
Cancer Inst. 99:1074–1085. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rao AV and Agarwal S: Bioavailability and
in vivo antioxidant properties of lycopene from tomato products and
their possible role in the prevention of cancer. Nutr Cancer.
31:199–203. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paetau I, Rao D, Wiley ER, Brown ED and
Clevidence BA: Carotenoids in human buccal mucosa cells after 4 wk
of supplementation with tomato juice or lycopene supplements. Am J
Clin Nutr. 70:490–494. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paetau I, Khachik F, Brown ED, Beecher GR,
Kramer TR, Chittams J and Clevidence BA: Chronic ingestion of
lycopene-rich tomato juice or lycopene supplements significantly
increases plasma concentrations of lycopene and related tomato
carotenoids in humans. Am J Clin Nutr. 68:1187–1195. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Yang Y and Wang Q: Lycopene can
reduce prostate-specific antigen velocity in a phase II clinical
study in Chinese population. Chin Med J (Engl). 127:2143–2146.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gann PH, Deaton RJ, Rueter EE, van Breemen
RB, Nonn L, Macias V, Han M and Ananthanarayanan V: A phase II
Randomized trial of lycopene-rich tomato extract among men with
high-grade prostatic intraepithelial neoplasia. Nutr Cancer.
67:1104–1112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Voskuil DW, Vrieling A, Korse CM, Beijnen
JH, Bonfrer JM, van Doorn J, Kaas R, Oldenburg HS, Russell NS,
Rutgers EJ, et al: Effects of lycopene on the insulin-like growth
factor (IGF) system in premenopausal breast cancer survivors and
women at high familial breast cancer risk. Nutr Cancer. 60:342–353.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lilly MB, Wu C, Ke Y, Chen WP, Soloff AC,
Armeson K, Yokoyama NN, Li X, Song L, Yuan Y, et al: A phase I
study of docetaxel plus synthetic lycopene in metastatic prostate
cancer patients. Clin Transl Med. 14:e16272024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Veeramachaneni S, Ausman LM, Choi SW,
Russell RM and Wang XD: High dose lycopene supplementation
increases hepatic cytochrome P4502E1 protein and inflammation in
alcohol-fed rats. J Nutr. 138:1329–1335. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanaka A, Miyauchi T, Kitamura S, Iwata H,
Hata H and Ujiie H: Carotenoderma due to lycopenemia: A case report
and evaluation of lycopene deposition in the skin. J Dermatol.
49:1320–1324. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reich P, Shwachman H and Craig JM:
Lycopenemia: A variant of carotenemia. N Engl J Med. 262:263–269.
1960. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Puah BP, Jalil J, Attiq A and Kamisah Y:
New Insights into molecular mechanism behind anti-cancer activities
of lycopene. Molecules. 26:38882021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tufail T, Bader Ul Ain H, Noreen S, Ikram
A, Arshad MT and Abdullahi MA: Nutritional benefits of lycopene and
beta-carotene: A comprehensive overview. Food Sci Nutr.
12:8715–8741. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cakir MA and Helvacioglu I:
Bioavailability and health effects of some carotenoids by different
cooking methods. Int J Gastro Res. 2:70–77. 2023.
|
|
39
|
Shruti R, Arshi S and Rajat S: Effect of
different processing and preservation techniques on lycopene: A
mini review. Res J Pharm Tech. 16:2537–2542. 2023.
|
|
40
|
Wu X, Zhu C, Zhang M, Wang S, Yu J, Tian J
and Hu Z: Effects of different processed tomatoes on carotenoid
release and microbiota composition during in vitro gastrointestinal
digestion and colonic fermentation. Food Funct. 14:10177–10187.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Geng T, Bao S, Sun X, Ma D, Zhang H, Ge Q,
Liu X and Ma T: A clarification of concepts related to the
digestion and absorption of carotenoids and a new standardized
carotenoids bioavailability evaluation system. Food Chem.
400:1340602023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yao Y, Yang Z, Yin B, Goh HM, Toh DWK and
Kim JE: Effects of dietary fat type and emulsification on
carotenoid absorption: A randomized crossover trial. Am J Clin
Nutr. 117:1017–1025. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Riedl J, Linseisen J, Hoffmann J and
Wolfram G: Some dietary fibers reduce the absorption of carotenoids
in women. J Nutr. 129:2170–2176. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Arballo J, Amengual J and Erdman JW Jr:
Lycopene: A critical review of digestion, absorption, metabolism,
and excretion. Antioxidants (Basel). 10:3422021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ozkan G, Gunal-Koroglu D, Karadag A,
Capanoglu E, Cardoso SM, Al-Omari B, Calina D, Sharifi-Rad J and
Cho WC: A mechanistic updated overview on lycopene as potential
anticancer agent. Biomed Pharmacother. 161:1144282023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang Y, Parmakhtiar B, Simoneau AR, Xie J,
Fruehauf J, Lilly M and Zi X: Lycopene enhances docetaxel's effect
in castration-resistant prostate cancer associated with
insulin-like growth factor I receptor levels. Neoplasia.
13:108–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen X, Yang G, Liu M, Quan Z, Wang L, Luo
C, Wu X and Zheng Y: Lycopene enhances the sensitivity of
castration-resistant prostate cancer to enzalutamide through the
AKT/EZH2/androgen receptor signaling pathway. Biochem Biophys Res
Commun. 613:53–60. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chan YP, Chuang CH, Lee I and Yang NC:
Lycopene in combination with sorafenib additively inhibits tumor
metastasis in mice xenografted with lewis lung carcinoma cells.
Front Nutr. 9:8869882022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
El-Masry TA, El-Nagar MMF, El Mahdy NA,
Alherz FA, Taher R and Osman EY: Potential antitumor activity of
combined lycopene and sorafenib against solid ehrlich carcinoma via
targeting autophagy and apoptosis and suppressing proliferation.
Pharmaceuticals (Basel). 17:5272024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Alhoshani NM, Al-Zharani M, Almutairi B,
Aljarba NH, Al-Johani NS, Alkeraishan N, AlKahtane AA, Alarifi S,
Ali D and Alkahtani S: Antioxidant and anti-inflammatory activities
of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2
cells. Saudi Pharm J. 30:1665–1671. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Aktepe OH, Sahin TK, Guner G, Arik Z and
Yalcin S: Lycopene sensitizes the cervical cancer cells to
cisplatin via targeting nuclear factor-kappa B (NF-ĸB) pathway.
Turk J Med Sci. 51:368–374. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Holzapfel NP, Shokoohmand A, Wagner F,
Landgraf M, Champ S, Holzapfel BM, Clements JA, Hutmacher DW and
Loessner D: Lycopene reduces ovarian tumor growth and
intraperitoneal metastatic load. Am J Cancer Res. 7:1322–1336.
2017.PubMed/NCBI
|
|
53
|
Jiang X, Wu H, Zhao W, Ding X, You Q, Zhu
F, Qian M and Yu P: Lycopene improves the efficiency of anti-PD-1
therapy via activating IFN signaling of lung cancer cells. Cancer
Cell Int. 19:682019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Peng M, Fan S, Li J, Zhou X, Liao Q, Tang
F and Liu W: Programmed death-ligand 1 signaling and expression are
reversible by lycopene via PI3K/AKT and Raf/MEK/ERK pathways in
tongue squamous cell carcinoma. Genes Nutr. 17:32022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vaishampayan U, Hussain M, Banerjee M,
Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes
JE and Kucuk O: Lycopene and soy isoflavones in the treatment of
prostate cancer. Nutr Cancer. 59:1–7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Langner E, Lemieszek MK and Rzeski W:
Lycopene, sulforaphane, quercetin, and curcumin applied together
show improved antiproliferative potential in colon cancer cells in
vitro. J Food Biochem. 43:e128022019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Linnewiel-Hermoni K, Khanin M, Danilenko
M, Zango G, Amosi Y, Levy J and Sharoni Y: The anti-cancer effects
of carotenoids and other phytonutrients resides in their combined
activity. Arch Biochem Biophys. 572:28–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pan X, Niu X, Li Y, Yao Y and Han L:
Preventive mechanism of lycopene on intestinal toxicity caused by
cyclophosphamide chemotherapy in mice by regulating
TLR4-MyD88/TRIF-TRAF6 signaling pathway and gut-liver axis.
Nutrients. 14:44672022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhu J, Hu Q and Shen S: Enhanced antitumor
efficacy and attenuated cardiotoxicity of doxorubicin in
combination with lycopene liposomes. J Liposome Res. 30:37–44.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sahin K, Tuzcu M, Sahin N, Ali S and Kucuk
O: Nrf2/HO-1 signaling pathway may be the prime target for
chemoprevention of cisplatin-induced nephrotoxicity by lycopene.
Food Chem Toxicol. 48:2670–2674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Turk G, Ceribasi AO, Sahna E and Atessahin
A: Lycopene and ellagic acid prevent testicular apoptosis induced
by cisplatin. Phytomedicine. 18:356–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tang C, Livingston MJ, Safirstein R and
Dong Z: Cisplatin nephrotoxicity: New insights and therapeutic
implications. Nat Rev Nephrol. 19:53–72. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Abdel-Latif R, Fathy M, Anwar HA, Naseem
M, Dandekar T and Othman EM: Cisplatin-induced reproductive
toxicity and oxidative stress: Ameliorative effect of kinetin.
Antioxidants (Basel). 11:8632022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Preet R, Mohapatra P, Das D, Satapathy SR,
Choudhuri T, Wyatt MD and Kundu CN: Lycopene synergistically
enhances quinacrine action to inhibit Wnt-TCF signaling in breast
cancer cells through APC. Carcinogenesis. 34:277–286. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Moselhy SS and Al mslmani MA:
Chemopreventive effect of lycopene alone or with melatonin against
the genesis of oxidative stress and mammary tumors induced by 7,12
dimethyl(a)benzanthracene in sprague dawely female rats. Mol Cell
Biochem. 319:175–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Limpens J, Schroder FH, de Ridder CM,
Bolder CA, Wildhagen MF, Obermuller-Jevic UC, Kramer K and van
Weerden WM: Combined lycopene and vitamin E treatment suppresses
the growth of PC-346C human prostate cancer cells in nude mice. J
Nutr. 136:1287–1293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tang FY, Pai MH, Kuo YH and Wang XD:
Concomitant consumption of lycopene and fish oil inhibits tumor
growth and progression in a mouse xenograft model of colon cancer.
Mol Nutr Food Res. 56:1520–1531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Velmurugan B and Nagini S: Combination
chemoprevention of experimental gastric carcinogenesis by
s-allylcysteine and lycopene: Modulatory effects on glutathione
redox cycle antioxidants. J Med Food. 8:494–501. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Al-Malki AL, Moselhy SS and Refai MY:
Synergistic effect of lycopene and tocopherol against oxidative
stress and mammary tumorigenesis induced by
7,12-dimethyl[a]benzanthracene in female rats. Toxicol Ind Health.
28:542–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wu H, Wu Y, Cui Z and Hu L: Nutraceutical
delivery systems to improve the bioaccessibility and
bioavailability of lycopene: A review. Crit Rev Food Sci Nutr.
64:6361–6379. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Carvalho GC, Sabio RM and Chorilli M: An
overview of properties and analytical methods for lycopene in
organic nanocarriers. Crit Rev Anal Chem. 51:674–686.
2021.PubMed/NCBI
|
|
72
|
Ahmad R, Srivastava S, Ghosh S and Khare
SK: Phytochemical delivery through nanocarriers: A review. Colloids
Surf B Biointerfaces. 197:1113892021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Llaguno-Munive M, Vazquez-Lopez MI and
Garcia-Lopez P: Solid lipid nanoparticles, an alternative for the
treatment of triple-negative breast cancer. Int J Mol Sci.
25:107122024. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mirchandani Y, Patravale VB and S B: Solid
lipid nanoparticles for hydrophilic drugs. J Control Release.
335:457–464. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ye J, Wang Q, Zhou X and Zhang N:
Injectable actarit-loaded solid lipid nanoparticles as passive
targeting therapeutic agents for rheumatoid arthritis. Int J Pharm.
352:273–279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Jain A, Sharma G, Kushwah V, Thakur K,
Ghoshal G, Singh B, Jain S, Shivhare US and Katare OP: Fabrication
and functional attributes of lipidic nanoconstructs of lycopene: An
innovative endeavour for enhanced cytotoxicity in MCF-7 breast
cancer cells. Colloids Surf B Biointerfaces. 152:482–491. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Santonocito D and Puglia C: Applications
of lipid-based nanocarriers for parenteral drug delivery. Curr Med
Chem. 29:4152–4169. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Katari O and Jain S: Solid lipid
nanoparticles and nanostructured lipid carrier-based
nanotherapeutics for the treatment of psoriasis. Expert Opin Drug
Deliv. 18:1857–1872. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Singh A, Neupane YR, Panda BP and Kohli K:
Lipid Based nanoformulation of lycopene improves oral delivery:
formulation optimization, ex vivo assessment and its efficacy
against breast cancer. J Microencapsul. 34:416–429. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang Y, Chen J, Shi L and Ma F: Polymeric
nanoparticle-based nanovaccines for cancer immunotherapy. Mater
Horiz. 10:361–392. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Pridgen EM, Alexis F and Farokhzad OC:
Polymeric nanoparticle technologies for oral drug delivery. Clin
Gastroenterol Hepatol. 12:1605–1610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Pridgen EM, Alexis F and Farokhzad OC:
Polymeric nanoparticle drug delivery technologies for oral delivery
applications. Expert Opin Drug Deliv. 12:1459–1473. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Miedema IHC, Zwezerijnen GJC, Huisman MC,
Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS,
Rijcken CJF, Vugts DJ, et al: PET-CT imaging of polymeric
nanoparticle tumor accumulation in patients. Adv Mater.
34:e22010432022. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Bano S, Ahmed F, Khan F, Chaudhary SC and
Samim M: Targeted delivery of thermoresponsive polymeric
nanoparticle-encapsulated lycopene: In vitro anticancer activity
and chemopreventive effect on murine skin inflammation and
tumorigenesis. RSC Adv. 10:16637–16649. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Jain A, Kesharwani P, Garg NK, Jain A,
Nirbhavane P, Dwivedi N, Banerjee S, Iyer AK and Iqbal Mohd Amin
MC: Nano-constructed carriers loaded with antioxidant: Boon for
cardiovascular system. Curr Pharm Des. 21:4456–4464. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yadollahi Z, Motiei M, Kazantseva N, Cisar
J and Saha P: Whey protein isolate-chitosan polyelectrolyte
nanoparticles as a drug delivery system. Molecules. 28:17242023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Chatterton DEW, Smithers G, Roupas P and
Brodkorb A: Bioactivity of β-lactoglobulin and
α-lactalbumin-Technological implications for processing. Int Dairy
J. 16:1229–1240. 2006. View Article : Google Scholar
|
|
88
|
Abbasi A, Emam-Djomeh Z, Mousavi MA and
Davoodi D: Stability of vitamin D(3) encapsulated in nanoparticles
of whey protein isolate. Food Chem. 143:379–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jain A, Sharma G, Ghoshal G, Kesharwani P,
Singh B, Shivhare US and Katare OP: Lycopene loaded whey protein
isolate nanoparticles: An innovative endeavor for enhanced
bioavailability of lycopene and anti-cancer activity. Int J Pharm.
546:97–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Singh Y, Meher JG, Raval K, Khan FA,
Chaurasia M, Jain NK and Chourasia MK: Nanoemulsion: Concepts,
development and applications in drug delivery. J Control Release.
252:28–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Li G, Zhang Z, Liu H and Hu L:
Nanoemulsion-based delivery approaches for nutraceuticals:
Fabrication, application, characterization, biological fate,
potential toxicity and future trends. Food Funct. 12:1933–1953.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Huang RF, Wei YJ, Inbaraj BS and Chen BH:
Inhibition of colon cancer cell growth by nanoemulsion carrying
gold nanoparticles and lycopene. Int J Nanomedicine. 10:2823–2846.
2015.PubMed/NCBI
|
|
93
|
Moammeri A, Chegeni MM, Sahrayi H,
Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Abtahi MS,
Hejabi F and Ren Q: Current advances in niosomes applications for
drug delivery and cancer treatment. Mater Today Bio. 23:1008372023.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mehrarya M, Gharehchelou B, Haghighi
Poodeh S, Jamshidifar E, Karimifard S, Farasati Far B, Akbarzadeh I
and Seifalian A: Niosomal formulation for antibacterial
applications. J Drug Target. 30:476–493. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kusdemir BC, Kozgus Guldu O, Yurt Kilcar A
and Medine EI: Preparation and in vitro investigation of
prostate-specific membrane antigen targeted lycopene loaded
niosomes on prostate cancer cells. Int J Pharm. 640:1230132023.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Spiliotaki M, Mavroudis D, Kokotsaki M,
Vetsika EK, Stoupis I, Matikas A, Kallergi G, Georgoulias V and
Agelaki S: Expression of insulin-like growth factor-1 receptor in
circulating tumor cells of patients with breast cancer is
associated with patient outcomes. Mol Oncol. 12:21–32. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Domingues C, Santos A, Alvarez-Lorenzo C,
Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M and Figueiras
A: Where is nano today and where is it headed? a review of
nanomedicine and the dilemma of nanotoxicology. ACS Nano.
16:9994–10041. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zu K, Mucci L, Rosner BA, Clinton SK, Loda
M, Stampfer MJ and Giovannucci E: Dietary lycopene, angiogenesis,
and prostate cancer: A prospective study in the prostate-specific
antigen era. J Natl Cancer Inst. 106:djt4302014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lu Y, Edwards A, Chen Z, Tseng TS, Li M,
Gonzalez GV and Zhang K: Insufficient lycopene intake is associated
with high risk of prostate cancer: A Cross-sectional study from the
national health and nutrition examination survey (2003–2010). Front
Public Health. 9:7925722021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wang Y, Cui R, Xiao Y, Fang J and Xu Q:
Effect of carotene and lycopene on the risk of prostate cancer: A
systematic review and dose-response meta-analysis of observational
studies. PLoS One. 10:e01374272015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ansari MS and Gupta NP: Lycopene: A novel
drug therapy in hormone refractory metastatic prostate cancer. Urol
Oncol. 22:415–420. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang X, Spiegelman D, Baglietto L,
Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM,
Giles GG, Giovannucci E, et al: Carotenoid intakes and risk of
breast cancer defined by estrogen receptor and progesterone
receptor status: A pooled analysis of 18 prospective cohort
studies. Am J Clin Nutr. 95:713–725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Gunter MJ, Hoover DR, Yu H,
Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett
J, Anderson GL, Ho GY, et al: Insulin, insulin-like growth
factor-I, endogenous estradiol, and risk of colorectal cancer in
postmenopausal women. Cancer Res. 68:329–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Walfisch S, Walfisch Y, Kirilov E, Linde
N, Mnitentag H, Agbaria R, Sharoni Y and Levy J: Tomato lycopene
extract supplementation decreases insulin-like growth factor-I
levels in colon cancer patients. Eur J Cancer Prev. 16:298–303.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Kim JH, Lee J, Choi IJ, Kim YI, Kwon O,
Kim H and Kim J: Dietary carotenoids intake and the risk of gastric
cancer: A case-control study in Korea. Nutrients. 10:10312018.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Jung S, Wu K, Giovannucci E, Spiegelman D,
Willett WC and Smith-Warner SA: Carotenoid intake and risk of
colorectal adenomas in a cohort of male health professionals.
Cancer Causes Control. 24:705–717. 2013.PubMed/NCBI
|
|
107
|
Ito Y, Kurata M, Hioki R, Suzuki K, Ochiai
J and Aoki K: Cancer mortality and serum levels of carotenoids,
retinol, and tocopherol: A population-based follow-up study of
inhabitants of a rural area of Japan. Asian Pac J Cancer Prev.
6:10–15. 2005.PubMed/NCBI
|
|
108
|
Huang X, Gao Y, Zhi X, Ta N, Jiang H and
Zheng J: Association between vitamin A, retinol and carotenoid
intake and pancreatic cancer risk: Evidence from epidemiologic
studies. Sci Rep. 6:389362016. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Tannock IF, de Wit R, Berry WR, Horti J,
Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, et
al: Docetaxel plus prednisone or mitoxantrone plus prednisone for
advanced prostate cancer. N Engl J Med. 351:1502–1512. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Kristal AR, Till C, Platz EA, Song X, King
IB, Neuhouser ML, Ambrosone CB and Thompson IM: Serum lycopene
concentration and prostate cancer risk: Results from the prostate
cancer prevention trial. Cancer Epidemiol Biomarkers Prev.
20:638–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Wang Y, Jacobs EJ, Newton CC and
McCullough ML: Lycopene, tomato products and prostate
cancer-specific mortality among men diagnosed with nonmetastatic
prostate cancer in the cancer prevention study II nutrition cohort.
Int J Cancer. 138:2846–2855. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
van Breemen RB, Sharifi R, Viana M,
Pajkovic N, Zhu D, Yuan L, Yang Y, Bowen PE and
Stacewicz-Sapuntzakis M: Antioxidant effects of lycopene in African
American men with prostate cancer or benign prostate hyperplasia: A
randomized, controlled trial. Cancer Prev Res (Phila). 4:711–718.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Jatoi A, Burch P, Hillman D, Vanyo JM,
Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, et
al: A tomato-based, lycopene-containing intervention for
androgen-independent prostate cancer: Results of a phase II study
from the North central cancer treatment group. Urology. 69:289–294.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Brown MJ, Ferruzzi MG, Nguyen ML, Cooper
DA, Eldridge AL, Schwartz SJ and White WS: Carotenoid
bioavailability is higher from salads ingested with full-fat than
with fat-reduced salad dressings as measured with electrochemical
detection. Am J Clin Nutr. 80:396–403. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Unlu NZ, Bohn T, Clinton SK and Schwartz
SJ: Carotenoid absorption from salad and salsa by humans is
enhanced by the addition of avocado or avocado oil. J Nutr.
135:431–436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Shareck M, Rousseau MC, Koushik A,
Siemiatycki J and Parent ME: Inverse association between dietary
intake of selected carotenoids and vitamin C and risk of lung
cancer. Front Oncol. 7:232017. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Min KB and Min JY: Serum carotenoid levels
and risk of lung cancer death in US adults. Cancer Sci.
105:736–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Prakash P, Russell RM and Krinsky NI: In
vitro inhibition of proliferation of estrogen-dependent and
estrogen-independent human breast cancer cells treated with
carotenoids or retinoids. J Nutr. 131:1574–1580. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Aust O, Stahl W, Sies H, Tronnier H and
Heinrich U: Supplementation with tomato-based products increases
lycopene, phytofluene, and phytoene levels in human serum and
protects against UV-light-induced erythema. Int J Vitam Nutr Res.
75:54–60. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zubair N, Kooperberg C, Liu J, Di C,
Peters U and Neuhouser ML: Genetic variation predicts serum
lycopene concentrations in a multiethnic population of
postmenopausal women. J Nutr. 145:187–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Crowe-White KM, Voruganti VS, Talevi V,
Dudenbostel T, Nagabooshanam VA, Locher JL and Ellis AC: Variation
of serum lycopene in response to 100% watermelon juice: An
exploratory analysis of genetic variants in a randomized controlled
crossover study. Curr Dev Nutr. 4:nzaa1022020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Moran NE, Thomas-Ahner JM, Fleming JL,
McElroy JP, Mehl R, Grainger EM, Riedl KM, Toland AE, Schwartz SJ
and Clinton SK: Single nucleotide polymorphisms in β-carotene
oxygenase 1 are associated with plasma lycopene responses to a
tomato-soy juice intervention in men with prostate cancer. J Nutr.
149:381–397. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Borel P, Desmarchelier C, Nowicki M and
Bott R: Lycopene bioavailability is associated with a combination
of genetic variants. Free Radic Biol Med. 83:238–244. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
D'Adamo CR, D'Urso A, Ryan KA,
Yerges-Armstrong LM, Semba RD, Steinle NI, Mitchell BD, Shuldiner
AR and McArdle PF: A common variant in the SETD7 gene predicts
serum lycopene concentrations. Nutrients. 8:822016. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Cui Y, Shikany JM, Liu S, Shagufta Y and
Rohan TE: Selected antioxidants and risk of hormone
receptor-defined invasive breast cancers among postmenopausal women
in the Women's Health Initiative Observational Study. Am J Clin
Nutr. 87:1009–1018. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Eliassen AH, Hendrickson SJ, Brinton LA,
Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman
MT, et al: Circulating carotenoids and risk of breast cancer:
Pooled analysis of eight prospective studies. J Natl Cancer Inst.
104:1905–1916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Yan B, Lu MS, Wang L, Mo XF, Luo WP, Du YF
and Zhang CX: Specific serum carotenoids are inversely associated
with breast cancer risk among Chinese women: A case-control study.
Br J Nutr. 115:129–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
